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Although more than 90% of melanomas have cutaneous 
origins, melanomas sometimes present metastatically with 
no apparent primary lesion. A 62-year-old female presented 
with black pigmentation on her left thumbnail that had 
begun 2 years earlier and after the biopsy, she was diagnosed 
with malignant melanoma. Interestingly, 7 years earlier, a 4 
cm palpable mass on her left axilla had been diagnosed as 
melanoma from an unknown primary site (MUP) with the 
involvement of an axillary lymph node. We speculate that 
the melanoma of the left thumb was the primary site and the 
melanoma in the axilla was a metastasis from the left thumb, 
and suggest several hypotheses explaining the appearance of 
the primary lesion as acral lentiginous melanoma after 
detecting a metastatic site. We consider this case interesting 
because it helps us to understand the pathogenesis of MUP 
and reminds physicians to conduct careful periodical 
work-ups of melanoma patients, and highlights the impor-
tance of continued long-term follow-up, especially for 
patients with MUP. (Ann Dermatol 23(S2) S274∼S278, 2011)
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INTRODUCTION
Melanoma occasionally occurs as apparent metastasis to 
lymph nodes or viscera without a detectable or known 
primary lesion, constituting the so-called melanoma from 
an unknown primary site (MUP). MUPs are estimated to 
comprise 3.7∼6.0% of all incidental melanomas
1. The 
clinical behavior and etiology of these lesions are poorly 
understood. We speculate that the melanoma of the left 
thumb was the primary site and the melanoma in the 
axilla was a metastasis from the left thumb and suggest 
several hypotheses explaining the appearance of the 
primary lesion as acral lentiginous melanoma (ALM) after 
detecting a metastatic site.
CASE REPORT
A 62-year-old female visited the Dermatology Department 
with spreading black pigmentation on her left thumbnail 
and brown macules on the periungual skin that had begun 
2 years earlier (Fig. 1). She underwent punch biopsies, 
which showed many hyperplastic atypical melanocytes 
with dermal invasion (Fig. 2A). The atypical melanocytes 
stained positively for both HMB-45 and S-100 protein (Fig. 
2B, C). We diagnosed the lesion as malignant melanoma, 
acral lentiginous type, and performed an evaluation that 
included computed tomography (CT), magnetic resonance 
imaging (MRI), and position emission tomography-com-Melanoma of Unknown Primary Site in which a Primary Site Became Apparent Five Years Later
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Fig. 1. There is a black patch on the proximal nail fold and mela-
nonychia of the left first fingernail.
puted tomography (PET-CT) to identify metastatic sites. 
However, no metastatic site was found and she underwent 
only left thumb amputation at the level of the inter-
phalangeal joint.
Interestingly, 7 years earlier, she had visited the Depart-
ment of Internal Medicine with a 4-cm palpable mass in 
the left axilla. On excision, it showed a histologically 
effaced nodal architecture involving wildly pleomorphic 
epithelioid cells with bizarre nuclei and variable amounts 
of dusty cytoplasmic pigment that stained with S100 and 
HMB-45, consistent with metastatic melanoma (Fig. 3). 
There was no family history of melanoma and she 
described her sun exposure as little to none. There was no 
history of previously excised pigmented cutaneous 
lesions. All the initial routine blood tests and chest x-rays 
were unremarkable. She underwent a full work-up, 
including CT, MRI, and PET-CT, to identify the primary 
site of the melanoma and underwent urogenital, otolaryn-
gologic, ophthalmologic, and other pertinent examina-
tions to exclude unusual primary sites. However, no 
primary site had been found and she was diagnosed with 
MUP at that time. 
She was so concerned about this left axillary melanoma 
that she felt as though something was in her left breast. 
Fig. 2. (A) The biopsy specimen from the left first finger shows
acanthosis, rete ridge elongation, and atypical melanocytes along
the dermo-epidermal junction (H&E, ×100). The atypical 
melanocytes react positively to (B) HMB-45 (HMB-45, ×100) and 
(C) S-100 (S-100, ×100).S Lee, et al
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Breast examination including mammography, MRI, and 
CT proved to be all normal but she wanted to widely 
remove her left breast. Thus she underwent a left-sided 
modified radical mastectomy with level III axillary lymph 
node dissection after thorough explanation of sequale-like 
lymphedema.
Three months later, she began to develop secondary 
lymphedema of the left arm. Following conservative treat-
ment with compression bandages, the lymphedema im-
proved slowly.
DISCUSSION
Although more than 90% of melanomas have cutaneous 
origins, melanomas may sometimes present metastatically 
in the absence of a primary lesion. The natural history of 
metastatic melanoma involving lymph nodes, in the 
absence of a known primary site (cutaneous, ocular, or 
mucosal) is unclear; consequently, the optimal manage-
ment of this rare subtype of disease also remains unclear. 
MUP is estimated to comprise 3.7∼6.0% of all melano-
mas
1.
We suggest several hypotheses explaining the appearance 
of the primary lesion as ALM after detecting a metastatic 
site (Fig. 4).
The first hypothesis is that a spontaneously regressed 
primary melanoma near the left thumbnail develops nodal 
metastasis and eventually recurs locally at the left 
thumbnail as a present illness. Regression is frequent in 
the natural history of melanoma. Melanomas undergo 
regression six times more often than do other malignant 
neoplasms
2. Features of partial regression of a primary 
cutaneous melanoma are observed in 10∼35% of cases
3. 
Total regression is much less common, but numerous 
cases have been reported in which the primary tumor 
underwent complete regression after the development of 
nodal and distant metastases. Therefore, the primary 
lesion was not found clinically because it had undergone 
regression, which was complete at the time of diagnosis of 
the metastatic disease. Subsequently, the primary lesion 
appears clinically when locally recurrent melanoma 
develops. Mahrle et al.
4 reported a patient with malignant 
Fig. 3. (A) The biopsy specimen from the left axilla mass shows
atypical cells with hyperchromatic and pleomorphic nuclei and 
melanin (H&E, ×40). The atypical melanocytes react positively 
to (B) HMB-45 (HMB-45, ×100) and (C) S-100 (S-100, ×100).Melanoma of Unknown Primary Site in which a Primary Site Became Apparent Five Years Later
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Fig. 4. Several hypotheses explai-
ning the appearance of the primary
site after detecting a metastatic 
lesion.
melanoma that underwent spontaneous regression with 
simultaneous development of a secondary tumor. The 
author’s assertion that "…regression of a melanoma may 
not prevent progression of the disease or formation of a 
new primary melanoma…" supports our hypothesis.
The primary site may have a slow growth rate; therefore, 
our second hypothesis is that the primary site rarely 
becomes manifest during the clinical course of the disease 
especially when the tumor shows an amelanotic picture. 
Recent evidence suggests that melanomas constitute a 
family of different tumors with varying abilities to grow 
and metastasize
5. ALM is characterized by slow lentigi-
nous radial growth and evolves slowly over many years
6. 
In our case, a slow-growing AML may explain why the 
primary site appeared after detecting a metastatic lesion.
The third hypothesis is that an amelanotic melanoma can 
be detected as the primary site after lymph node 
metastasis. The lack of pigmentation causes the clinical 
appearance to be nonspecific for melanoma, so that it is 
difficult to find clinically. Subsequently, the amelanotic 
melanoma may gradually develop a pigmented lesion, 
which can be detected clinically. Karine reported that 
amelanotic lesions in albino mice developed foci of dark 
pigmentation
7. He suggested that late events occurring 
within the amelanotic melanoma generate some tyro-
sinase activity and the production of melanin.
The last hypothesis is that the primary site of the 
metastatic axillary melanoma regressed spontaneously and 
that a new melanoma lesion (the thumbnail melanoma) 
was detected and was one of multiple primary melano-
mas. The incidence of multiple primary melanomas is 1∼
8% and the incidence of ALM in Asians is higher than in 
other ethnic groups; in Korea, the most common type of 
melanoma is ALM
8. However, ALM is associated with a 
lower incidence of multiple primary melanomas than 
sporadic nonacral melanoma
9,10. To the best of our 
knowledge, there are no available studies demonstrating 
an increased incidence of developing a second melanoma 
on an acral site in Asian patients. 
Although it was impossible to confirm that the melanoma 
of the left thumb was the primary site, we consider this 
case interesting because it helps us to understand the 
pathogenesis of MUP and reminds physicians to conduct 
careful periodical work-ups of melanoma patients; it also 
highlights the importance of continued long-term follow- 
up, especially in patients with MUP.
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